Stockreport

Emory begins enrolment for BioCardia's trial of ischemic heart failure therapy [Yahoo! Finance]

BioCardia, Inc.  (BCDA) 
PDF The trial is assessing BioCardia's lead product candidate for individuals with ischemic heart failure of minimised ejection fraction and elevated cardiac stress markers [Read more]